PHAROMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHAROMED
Largest movements
- Receivables within one year +€37,251
up €37,251 (+23.8%), from €156,511 to €193,762
of which Other amounts receivable: +€22,229
- Cash -€4,025
down €4,025 (-74.9%), from €5,376 to €1,351
mainly Receivables within one year (-€37,251) and Trade debts (-€34,267)
- Trade debts -€34,267
down €34,267 (-51.9%), from €66,030 to €31,763
- Reserves +€30,000
up €30,000 (+1,581%), from €1,897 to €31,897
- Profit (loss) carried forward -€26,707
down €26,707 (-96.5%), from €27,671 to €964
- Other debts +€25,000
up €25,000 (+397%), from €6,300 to €31,300
- Short-term financial debts +€23,150
new in 2025: €23,150
- Gross operating margin +€15,661
up €15,661 (+48.7%), from €32,145 to €47,806
- Taxes +€5,041
up €5,041 (+97.6%), from €5,166 to €10,208
- Financial charges +€755
up €755 (+14.2%), from €5,333 to €6,088
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €168,002 | €198,153 | +€30,151 | +17.9% |
| Fixed assets | 21/28 | €3,574 | €1,681 | -€1,894 | -53.0% |
| Tangible fixed assets | 22/27 | €3,574 | €1,681 | -€1,894 | -53.0% |
| Furniture and vehicles | 24 | €3,574 | €1,681 | -€1,894 | -53.0% |
| Current assets | 29/58 | €164,428 | €196,472 | +€32,044 | +19.5% |
| Amounts receivable within one year | 40/41 | €156,511 | €193,762 | +€37,251 | +23.8% |
| Trade receivables | 40 | €81,259 | €96,281 | +€15,022 | +18.5% |
| Other amounts receivable | 41 | €75,252 | €97,481 | +€22,229 | +29.5% |
| Cash at bank and in hand | 54/58 | €5,376 | €1,351 | -€4,025 | -74.9% |
| Deferred charges and accrued income | 490/1 | €2,541 | €1,359 | -€1,182 | -46.5% |
| Total equity and liabilities | 10/49 | €168,002 | €198,153 | +€30,151 | +17.9% |
| Equity | 10/15 | €35,954 | €39,248 | +€3,293 | +9.2% |
| Contributions | 10/11 | €6,386 | €6,386 | = | 0.0% |
| Reserves | 13 | €1,897 | €31,897 | +€30,000 | +1,581% |
| Distributable reserves | 133 | €1,897 | €31,897 | +€30,000 | +1,581% |
| Profit (loss) carried forward | 14 | €27,671 | €964 | -€26,707 | -96.5% |
| Amounts payable | 17/49 | €132,048 | €158,905 | +€26,858 | +20.3% |
| Amounts payable after more than one year | 17 | €29,134 | €21,471 | -€7,663 | -26.3% |
| Financial debts | 170/4 | €29,134 | €21,471 | -€7,663 | -26.3% |
| Amounts payable within one year | 42/48 | €102,914 | €135,661 | +€32,747 | +31.8% |
| Current portion of amounts payable after more than one year | 42 | €7,033 | €7,663 | +€629 | +9.0% |
| Financial debts | 43 | - | €23,150 | +€23,150 | |
| Credit institutions | 430/8 | - | €23,150 | +€23,150 | |
| Trade debts | 44 | €66,030 | €31,763 | -€34,267 | -51.9% |
| Suppliers | 440/4 | €66,030 | €31,763 | -€34,267 | -51.9% |
| Taxes, remuneration and social security | 45 | €23,551 | €41,785 | +€18,234 | +77.4% |
| Taxes | 450/3 | €13,774 | €22,765 | +€8,991 | +65.3% |
| Remuneration and social security | 454/9 | €9,777 | €19,020 | +€9,242 | +94.5% |
| Other amounts payable | 47/48 | €6,300 | €31,300 | +€25,000 | +397% |
| Accrued charges and deferred income | 492/3 | - | €1,774 | +€1,774 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,910 | €1,894 | -€16 | -0.9% |
| Other operating charges | 640/8 | €1,355 | €1,361 | +€6 | +0.5% |
| Non-recurring operating charges | 66A | €4,454 | - | -€4,454 | |
| Gross operating margin | 9900 | €32,145 | €47,806 | +€15,661 | +48.7% |
| Operating profit (loss) | 9901 | €24,426 | €44,551 | +€20,125 | +82.4% |
| Financial income | 75/76B | €0 | €38 | +€37 | +9,826% |
| Recurring financial income | 75 | €0 | €38 | +€37 | +9,826% |
| Financial charges | 65/66B | €5,333 | €6,088 | +€755 | +14.2% |
| Recurring financial charges | 65 | €5,333 | €6,088 | +€755 | +14.2% |
| Profit (loss) for the period before taxes | 9903 | €19,093 | €38,501 | +€19,408 | +102% |
| Income taxes | 67/77 | €5,166 | €10,208 | +€5,041 | +97.6% |
| Profit (loss) for the period | 9904 | €13,927 | €28,293 | +€14,366 | +103% |
| Profit (loss) for the period to be appropriated | 9905 | €13,927 | €28,293 | +€14,366 | +103% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.